"10.1371_journal.pone.0100883","plos one","2014-06-26T00:00:00Z","Nuruddeen D Lewis; Lori A Patnaude; Josephine Pelletier; Donald J Souza; Susan M Lukas; F James King; Jonathan D Hill; Dimitria E Stefanopoulos; Kelli Ryan; Sudha Desai; Donna Skow; Stefan G Kauschke; Andre Broermann; Daniel Kuzmich; Christian Harcken; Eugene R Hickey; Louise K Modis","Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America; Research Networking, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America; CardioMetabolic Diseases Research, Boehringer Ingelheim Pharmaceuticals Inc., Biberach, Germany; Medicinal Chemistry, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America","Conceived and designed the experiments: NDL LAP DS SML JDH KR DJS LKM. Performed the experiments: NDL LAP JP SML DES KR SD DS. Analyzed the data: NDL LAP JP DS SML FJK JDH DES KR DJS. Contributed reagents/materials/analysis tools: SGK AB DK CH ERH. Wrote the paper: LKM NDL FJK LAP.","All authors were employees of Boehringer Ingelheim Pharmaceuticals, whose company funded this study, when the work was performed. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2014","06","Nuruddeen D Lewis","NDL",17,TRUE,8,8,10,4,TRUE,TRUE,FALSE,0,NA,FALSE
